Inhibition of LTβR/LIGHT signaling through KO of the receptor or ligand, or addition of biologically inactive ligand reduced colony formation and LSC frequency, while it prolonged survival in a murine MLL-AF9-driven AML model. The gene discussed is KMT2A; the disease is acute myeloid leukemia.